Arvinas, Inc. (ARVN)

NASDAQ

$7.54

$-0.27

(-3.52%)

Pre-Market

Arvinas, Inc. (ARVN) Live Price Chart

Last updated: ⁦2026-10-22 12:24:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Arvinas, Inc. (ARVN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $7.54, with a market capitalization of $500.86M and a P/E ratio of 53.15. Over the past 52 weeks, its price has ranged from $6.74 to $14.51. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$500.86M
Open	$7.81
Day's High	$108.47
Day's Low	$5.90
Previous Close	$7.56
Volume	115.00
Average Volume	804.63K
P/E Ratio	53.15
52-Week High	$14.51
52-Week Low	$6.74
Dividend Yield	--
Earnings Date	--

Arvinas, Inc. (ARVN) Pre-Market Stock Price

Arvinas, Inc. (ARVN) is trading at $7.54 in pre-market trading as of 2026-10-22 10:09:00, down 0.26% ($0.02) from the previous close of $7.56

Pre-market trading shows how investors are pricing ARVN before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.

Arvinas, Inc. (ARVN) 7-Day Stock Price Change

Over the past seven days, Arvinas, Inc. (ARVN) moved from $6.84 to $7.54, representing a gain of 10.16% ($0.70).

The stock traded between $6.74 and $7.81 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 723.90 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

ARVN 52-Week Price Position

Position in Range: 10.2%

52W Low$6.74

52W High$14.51

ARVN is currently trading at $7.54, placing it 10.2% of the way from its 52-week low of $6.74 to its 52-week high of $14.51. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Arvinas, Inc. (ARVN)?

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Arvinas, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	246
Exchange	NASDAQ
Company Website	https://www.arvinas.com

How to Buy Arvinas, Inc. (ARVN) Stock on MEXC

Eligible investors can buy real shares of Arvinas, Inc. (ARVN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ARVN and Place Your Order

Open the RealStocks trading page and search for ARVN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Arvinas, Inc. (ARVN) stock price today?

Arvinas, Inc. (ARVN) is currently trading at $ 7.54, down 0.26% ($0.02) from the previous close of $ 7.56. Intraday prices update in real time during regular trading hours.

2.Is ARVN stock going up or down today?

As of 2026-10-22 10:09:00, ARVN is trading at $ 7.54, down 0.26% ($0.02) from its previous close of $ 7.56. The stock has traded between $ 5.90 and $ 108.47 during today’s regular session. Past price movements do not guarantee future results.

3.What is ARVN pre-market price?

As of 2026-10-22 10:09:00, ARVN is trading at $ 7.54 in pre-market trading, down 0.26% ($0.02) from the previous close of $ 7.56. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ARVN after-hours price?

As of 2026-10-22 10:09:00, ARVN is trading at $ 7.81 in after-hours trading, up 3.38% ($0.25) from the regular-session close of $ 7.56. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ARVN stock trading now?

ARVN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ARVN sit relative to its 52-week high and low?

Over the past 52 weeks, ARVN has traded between a low of $ 6.74 and a high of $ 14.51. At $ 7.54, the stock is positioned 10.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Arvinas, Inc. in?

Arvinas, Inc. (ARVN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Arvinas, Inc.'s market capitalization and where is it listed?

Arvinas, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 500.86M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ARVN valued in terms of P/E ratio and EPS?

ARVN trades at a P/E ratio of 53.15, based on trailing-twelve-month EPS of $ 0.14. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Arvinas, Inc. pay a dividend?

Arvinas, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.